310. Congenital anomalies syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 11 / Drugs : 20 - (DrugBank : 10) / Drug target genes : 3 - Drug target pathways : 7
Congenital anomalies syndrome and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
| ID | Diseases (Sorted by drug repositionability) |
|---|---|
| 310 | Congenital anomalies syndrome |
| 6 | Parkinson disease |
| 46 | Malignant rheumatoid arthritis |
| 96 | Crohn disease |
| 97 | Ulcerative colitis |
| 263 | Cerebrotendinous xanthomatosis |
| 280 | Huge arteriovenous malformation with cervicofacial or limb lesion |
| 94 | Primary sclerosing cholangitis |
| 265 | Lipodystrophy |
| 93 | Primary biliary cholangitis |
| 67 | Polycystic kidney disease |
| 271 | Ankylosing spondylitis |
| 298 | Hereditary pancreatitis |
| 84 | Sarcoidosis |
| 299 | Cystic fibrosis |
| 86 | Pulmonary arterial hypertension |
| 51 | Scleroderma |
| 13 | Multiple sclerosis/Neuromyelitis optica |